# Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline

> **NCT02123576** · NA · TERMINATED · sponsor: **Patrick Northup, MD** · enrollment: 12 (actual)

## Conditions studied

- Hepatorenal Syndrome

## Interventions

- **DRUG:** Pentoxyfylline
- **DRUG:** Placebo
- **DRUG:** AMO Therapy

## Key facts

- **NCT ID:** NCT02123576
- **Lead sponsor:** Patrick Northup, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Poor enrollment of study population
- **Last updated:** 2019-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02123576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02123576, "Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02123576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*